Literature DB >> 3447890

Statistical properties of a two-stage model of carcinogenesis.

C J Portier1.   

Abstract

Some of the statistical properties of a simple two-stage model of carcinogenesis are explored. The implications of additive treatment effects versus independent treatment effects on the shape of the dose-response curve are considered. Response that is low-dose linear results in the cases where the mutation rates are affected by dose or in the cases where treatment changes the birth rate/death rate of initiated cells in an additive fashion. Independent treatment effects lead to non-low-dose linear response when the survival of initiated cells is affected by treatment. A computer simulation experiment was performed that examined the ability of animal carcinogenesis data to differentiate between various forms of this simple two-stage model. It is shown that animal carcinogenicity experiments do not contain enough data to adequately describe the difference between these two types of effects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3447890      PMCID: PMC1474463          DOI: 10.1289/ehp.8776125

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  14 in total

1.  Hereditary cancer, oncogenes, and antioncogenes.

Authors:  A G Knudson
Journal:  Cancer Res       Date:  1985-04       Impact factor: 12.701

2.  Effect of aging in two-stage carcinogenesis on mouse skin with phorbol myristate acetate as promoting agent.

Authors:  B L Van Duuren; A C Smith; S M Melchionne
Journal:  Cancer Res       Date:  1978-03       Impact factor: 12.701

3.  Carcinogenic risk assessment: a guide to the literature.

Authors:  D Krewski; C Brown
Journal:  Biometrics       Date:  1981-06       Impact factor: 2.571

4.  Two-stage model for carcinogenesis: Epidemiology of breast cancer in females.

Authors:  S H Moolgavkar; N E Day; R G Stevens
Journal:  J Natl Cancer Inst       Date:  1980-09       Impact factor: 13.506

5.  Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments.

Authors:  C J Portier; J C Hedges; D G Hoel
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

6.  The two-mutational-event theory in medullary thyroid cancer.

Authors:  C E Jackson; M A Block; K A Greenawald; A H Tashjian
Journal:  Am J Hum Genet       Date:  1979-11       Impact factor: 11.025

7.  A new theory on cancer-inducing mechanism.

Authors:  C O NORDLING
Journal:  Br J Cancer       Date:  1953-03       Impact factor: 7.640

8.  Model for human carcinogenesis: action of environmental agents.

Authors:  S H Moolgavkar
Journal:  Environ Health Perspect       Date:  1983-04       Impact factor: 9.031

9.  The age distribution of cancer and a multi-stage theory of carcinogenesis.

Authors:  P ARMITAGE; R DOLL
Journal:  Br J Cancer       Date:  1954-03       Impact factor: 7.640

10.  Initiation and promotion at different ages and doses in 2200 mice. I. Methods, and the apparent persistence of initiated cells.

Authors:  F Stenbäck; R Peto; P Shubik
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640

View more
  4 in total

1.  Low-dose radiation and genotoxic chemicals can protect against stochastic biological effects.

Authors:  Bobby R Scott; Dale M Walker; Vernon E Walker
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-07

Review 2.  Using cell replication data in mathematical modeling in carcinogenesis.

Authors:  C J Portier; A Kopp-Schneider; C D Sherman
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

3.  A model-free approach to low-dose extrapolation.

Authors:  D Krewski; D Gaylor; M Szyszkowicz
Journal:  Environ Health Perspect       Date:  1991-01       Impact factor: 9.031

4.  Receptor mechanisms and dose-response models for the effects of dioxins.

Authors:  G W Lucier; C J Portier; M A Gallo
Journal:  Environ Health Perspect       Date:  1993-04-22       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.